No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

OKTO Launches: New Approach for Pain Management Reports NDIBA®

Editor: What To Know

  • OKTO, is a a radiofrequency equipment with a stable 448kHz current perfect for treating acute and chronic pain, based on high-frequency neuromodulation of pain and metabolic stimulation of biological tissues.
  • OKTO’s eight active channels will allow professionals to work superficially or with full depth depending on the anatomical needs of each situation or pathology acting over the spine ganglions or over the peripheral nerve system giving an anthineuralgic and antineurithic effect.
  • “Additionally, it will help clinics to save time and resources during consultation while offering the INDIBA guarantee of results on pain management,”.

OKTO, is a a radiofrequency equipment with a stable 448kHz current perfect for treating acute and chronic pain, based on high-frequency neuromodulation of pain and metabolic stimulation of biological tissues.

“This hands-free equipment is a revolutionaly approach for pain management. It improves musculoskeletal and joint pain such as neuropathies, discopathies, osteoarthritis, osteochondrosis and post-traumatic injuries,” says Remco Schmitz, INDIBA CEO.

“Additionally, it will help clinics to save time and resources during consultation while offering the INDIBA guarantee of results on pain management,” says Diederik van Goor, ACTIV business unit leader.

At the heart of INDIBA Solutions, this device is targeted to Chiropractors, Physiotherapists, Pain Medicine, Physical therapists, Sports medicine specialists, Sports injury specialists, osteopaths, and Physical Rehab doctors.

The mechanism of action combines its scientifically proven enhancement of stem cell proliferation with the stimulation of neurovascular zones. OKTO’s eight active channels will allow professionals to work superficially or with full depth depending on the anatomical needs of each situation or pathology acting over the spine ganglions or over the peripheral nerve system giving an anthineuralgic and antineurithic effect.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy